2. Academic Validation
  3. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides

Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides

  • J Med Chem. 1996 Dec 20;39(26):5159-75. doi: 10.1021/jm960487f.
S E Draheim 1,  N J Bach,  R D Dillard,  D R Berry,  D G Carlson,  N Y Chirgadze,  D K Clawson,  L W Hartley,  L M Johnson,  N D Jones,  E R McKinney,  E D Mihelich,  J L Olkowski,  R W Schevitz,  A C Smith,  D W Snyder,  C D Sommers,  J P Wery
Affiliations

Affiliation

  • 1 Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
PMID: 8978844 DOI: 10.1021/jm960487f
Abstract

The preceding papers of this series detail the development of functionalized indole-3-acetamides as inhibitors of hnps-PLA2. We describe here the extension of the structure-activity relationship to include a series of indole-3-glyoxamide derivatives. Functionalized indole-3-glyoxamides with an acidic substituent appended to the 4- or 5-position of the indole ring were prepared and tested as inhibitors of hnps-PLA2. It was found that the indole-3-glyoxamides with a 4-oxyacetic acid substituent had optimal inhibitory activity. These inhibitors exhibited an improvement in potency over the best of the indole-3-acetamides, and LY315920 (6m) was selected for evaluation clinically as an hnps-PLA2 inhibitor.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z